A constellation of defective proteins suspected in causing a malfunction in the body’s ability to repair its own DNA could be the link scientists need…

Yale Cancer Center researchers have shown that a tiny genetic variation predicts chances of survival and response to treatment for patients with ovarian cancer.

The findings, published in the…

A new strategy that takes advantage of ovarian cancer’s reliance on folate appears to give relapse patients extra months of life with few side effects,…

Among women with a certain type of high-grade ovarian cancer, having BRCA2 genetic mutations, but not BRCA1, was associated with improved overall survival and…

Women with high-grade ovarian cancer live longer and respond better to platinum-based chemotherapy when their tumors have BRCA2 genetic mutations, researchers at The University of Texas MD…

Ovarian cancer is one of the most frequent forms of cancer that affect women. As tumors can initially grow unchecked in the abdomen without causing any major symptoms, patients are…

A common chemotherapy drug has been successfully delivered to cancer cells inside tiny microparticles using a method inspired by our knowledge of how the human immune…

Approval last week by U.S. Food and Drug Administration (FDA) clears the path for nationwide use of tools that show the greatest specificity in estimating the risk of ovarian cancer…

Researchers at the University of Michigan Comprehensive Cancer Center have found that a type of normal stem cell fuels ovarian cancer by encouraging…

Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered that a low dose of the opioid antagonist naltrexone (LDN)…

Cancer is not invincible but its weaknesses can be difficult to detect. An effort known as Project Achilles - named after the Greek warrior whose one vulnerability led to his…

As part of The Cancer Genome Atlas (TCGA) projectIcon indicating that a link will open an external site., UNC Lineberger researchers have contributed to the most comprehensive and…

Roche Holding AG, the world’s leader in oncology drugs, struck an upbeat tone about approval prospects for its key drug Avastin in ovarian cancer ahead of an important industry meeting…

Once a woman begins experiencing symptoms of ovarian cancer, getting diagnosed and treated quickly may not help her survive longer, according to a new study of Australian women.

The…

A motor regulatory protein can block human ovarian tumor growth, leading to eventual cancer cell death and possible new therapies to treat the disease, according to Penn State…

Researchers at Oregon Health & Science University’s Oregon National Primate Research Center may have good news for women…

Family doctors can take more than a month to record ovarian cancer, once diagnosed by a specialist, in one in 10…

Cancer researchers have discovered that a type of regulatory RNA may be effective in fighting ovarian cancer. Ovarian cancer isn’t typically discovered until it’s in the…

György Horvath from the University of Gothenburg, Sweden, and researchers from the University of Gävle and KTH Royal Institute of Technology have been able to confirm in tests that ovarian cancer tissue and…

The best currently available screening tests can only slightly reduce ovarian cancer deaths. That is the conclusion of new research published early online in Cancer, a peer-reviewed journal of the American…

Cancer prevention experts have long been frustrated by the lack of a meaningful way to screen women for ovarian cancer. It is a relatively rare disease that often…

Drug resistance is a major obstacle in curing ovarian cancer but new research from the Centenary Institute has discovered a treatment that kills ovarian cancer cells in a…

Roche’s blockbuster drug Avastin helps women with ovarian cancer live longer without their disease getting worse, but its effect peaks at 12 months and then diminishes, researchers said on…

A consortium of cancer researchers has identified four chromosome locations with genetic changes that are likely to alter a woman’s risk of developing ovarian cancer. The findings appear in…

An international consortium of scientists has discovered new genetic variants in five regions of the genome that affect the risk of ovarian cancer in the general population,…